Sterile, virtually painless in-clinic administration of specialized anti-VEGF and steroid medications for macular edema, AMD, and diabetic eye disease.
Intravitreal injections deliver concentrated therapeutic agents directly into the vitreous humor adjacent to the retina, maximizing drug effectiveness while avoiding systemic side effects.
If you experience any of the following symptoms, schedule a comprehensive retinal and eye evaluation promptly:
Prof. Dr. Md. Arif Hayat Khan Pathan provides personalized treatment regimens adhering to international ophthalmic standards:
Aflibercept (Eylea)
Ranibizumab (Lucentis / Accentrix)
Bevacizumab (Avastin)
Dexamethasone Sustained-Release Implant (Ozurdex)
Performed in dedicated sterile ophthalmic procedure suites, intravitreal injections have transformed retinal care. Dr. Arif Pathan utilizes tiny 30-gauge needles with pre- and post-injection antiseptic protocols to ensure utmost comfort and safety.
Triple fellowship holder: FRCS (Glasgow), FRCS (Edinburgh), and ICO (UK) in posterior segment surgery.
State-of-the-art micro-incision instrumentation delivering faster healing and minimal discomfort.
Complete diagnostic array including HD-OCT, FFA, and modern phacoemulsification suites.
Over 8,000 satisfied patients across Bangladesh treated with compassion and clinical integrity.
No. Topical anesthetic drops thoroughly numb the surface of the eye. Most patients report feeling only light pressure for a few seconds.
Diabetic Eye DiseaseAugust 15, 2026
Cataract & Lens SurgeryJuly 30, 2026
Macular DisordersJuly 15, 2026